ImpediMed Ltd
ASX:IPD
ImpediMed Ltd
Total Liabilities
ImpediMed Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ImpediMed Ltd
ASX:IPD
|
Total Liabilities
AU$21.2m
|
CAGR 3-Years
40%
|
CAGR 5-Years
30%
|
CAGR 10-Years
21%
|
|
|
Somnomed Ltd
ASX:SOM
|
Total Liabilities
AU$34.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
18%
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Total Liabilities
AU$19.8m
|
CAGR 3-Years
17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
18%
|
|
|
Cochlear Ltd
ASX:COH
|
Total Liabilities
AU$855.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Total Liabilities
AU$39.3m
|
CAGR 3-Years
53%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Total Liabilities
AU$6.3m
|
CAGR 3-Years
64%
|
CAGR 5-Years
67%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
Glance View
ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland and currently employs 73 full-time employees. The company went IPO on 2007-10-24. The firm develops various medical products that use bioimpedance spectroscopy (BIS) to measure and monitor fluid status and tissue composition. Its product includes SOZO Digital Health Platform. The company is a non-invasive BIS device delivers a snapshot of fluid status and tissue composition in approximately 30 seconds. The Company’s SOZO Applications offer clinicians deeper insights into a patient’s health. SOZO Applications include various software applications, such as L-Dex Analysis for Lymphedema, Body Composition Analysis, Segmental Analysis and HF-Dex Analysis for Heart Failure. The Company’s research devices include SFB7 and ImpediVET. SFB7 single channel, tetrapolar BIS device, which measures fluid status and tissue composition for clinical and research applications.
See Also
What is ImpediMed Ltd's Total Liabilities?
Total Liabilities
21.2m
AUD
Based on the financial report for Jun 30, 2025, ImpediMed Ltd's Total Liabilities amounts to 21.2m AUD.
What is ImpediMed Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
21%
Over the last year, the Total Liabilities growth was 239%. The average annual Total Liabilities growth rates for ImpediMed Ltd have been 40% over the past three years , 30% over the past five years , and 21% over the past ten years .
